A forthcoming Brexit, extra taxes on medical devices, OTC markets, and an unruly Donald Trump – it all creates political and regulatory uncertainty. However, it does not discourage CEO in GN Hearing, Anders Hedegaard. “We are well placed to deliver,” he says.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.